Ticker
SCYXCompany Name
SCYNEXIS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -19.29M | -592.14% | $ 3.26M |
3/31/2025 | $ -26.67M | -1013.99% | $ 2.63M |
12/31/2024 | $ -20.31M | -542.15% | $ 3.75M |
9/30/2024 | $ -35.2M | -410.94% | $ 8.57M |
6/30/2024 | $ -33.61M | -347.67% | $ 9.67M |
3/31/2024 | $ 104.31M | 74.31% | $ 140.38M |
12/31/2023 | $ 70.89M | 50.58% | $ 140.14M |
9/30/2023 | $ 77.24M | 56.85% | $ 135.87M |
6/30/2023 | $ 50.58M | 37.29% | $ 135.66M |
3/31/2023 | $ -85.05M | -1536.79% | $ 5.53M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for SCYNEXIS INC is calculated as follows: EBITDA [ $ -29.02M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |